Abstract
The human hematopoietic differentiation in vitro of human pluripotent stem cells (hPSCs) has provided new tools to elucidate the mechanisms of related genetic abnormalities, such as congenital diseases and acquired hematopoietic malignancies, and to discover new treatments. The differentiation can also be applied to developing a stable source of blood products for transfusion with minimal risk of several blood-borne infections. We previously proposed a method for hematopoietic progenitor cell (HPC) differentiation, the “hPSC-sac method”, in which hPSCs are cocultured with C3H10T1/2 mouse stromal cells and mixed with a single cytokine, VEGF. The hPSC-sac method can differentiate hPSCs to multiple blood lineages. Here we describe improvements in the method by adding bFGF, TGFβ inhibitor and heparin to the culture, which increases the yield of CD34+CD43+ HPCs 50-fold compared with the original protocol. This revised hPSC-sac method is expected to contribute to the development of disease models and regenerative medicine using hematopoietic lineage cells.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Wang L, Li L, Shojaei F et al (2004) Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity 21:31–41
Takayama N, Nishikii H, Usui J et al (2008) Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors. Blood 111:5298–5306
Niwa A, Heike T, Umeda K et al (2011) A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors. PLoS One 6:e22261
Chou ST, Byrska-Bishop M, Tober JM et al (2012) Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A 109:17573–17578
Sturgeon CM, Ditadi A, Awong G et al (2014) Wnt signaling controls the specification of definitive and primitive hematopoiesis from human pluripotent stem cells. Nat Biotechnol 32:554–561
Hansen M, von Lindern M, van den Akker E et al (2019) Human-induced pluripotent stem cell-derived blood products: state of the art and future directions. FEBS Lett 593:3288–3303
Takayama N, Eto K (2012) In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells. In: Gibbins JM, Mahaut-Smith MP (eds) Seminars in hematology. Springer, New York, pp 205–217
Takayama N, Nishimura S, Nakamura S et al (2010) Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells. J Exp Med 207:2817–2830
Nakamura S, Takayama N, Hirata S et al (2014) Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells. Cell Stem Cell 14:535–548
Ito Y, Nakamura S, Sugimoto N et al (2018) Turbulence activates platelet biogenesis to enable clinical scale ex vivo production. Cell:1–13
Ochi K, Takayama N, Hirose S et al (2014) Multicolor staining of globin subtypes reveals impaired globin switching during erythropoiesis in human pluripotent stem cells. Stem Cells Transl Med 3:792–800
Hirata S, Takayama N, Jono-Ohnishi R et al (2013) Congenital amegakaryocytic thrombocytopenia iPS cells exhibit defective MPL-mediated signaling. J Clin Invest 123:3802–3814
Miyauchi M, Koya J, Arai S et al (2018) ADAM8 is an antigen of tyrosine kinase inhibitor-resistant chronic myeloid leukemia cells identified by patient-derived induced pluripotent stem cells. Stem Cell Reports 10:1115–1130
Nishimura T, Kaneko S, Kawana-tachikawa A et al (2013) Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation. Cell Stem Cell 12:114–126
Suemori H, Yasuchika K, Hasegawa K et al (2006) Efficient establishment of human embryonic stem cell lines and long-term maintenance with stable karyotype by enzymatic bulk passage. Biochem Biophys Res Commun 345:926–932
Hiroyama T, Miharada K, Aoki N et al (2006) Long-lasting in vitro hematopoiesis derived from primate embryonic stem cells. Exp Hematol 34:760–769
Yuzuriha A, Nakamura S, Sugimoto N et al (2021) Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Stem Cell Res 53:102287
Nakagawa M (2014) Center for iPS cell research and application (CiRA). https://www.cira.kyoto-u.ac.jp/e/research/protocol.html. Accessed 14 Nov 2020
Adelman DM, Maltepe E, Simon MC (1999) Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev 13:2478–2483
Ramírez-Bergeron DL, Runge A, Cowden Dahl KD et al (2004) Hypoxia affects mesoderm and enhances hemangioblast specification during early development. Development 131:4623–4634
Han Y, Kuang SZ, Gomer A et al (2010) Hypoxia influences the vascular expansion and differentiation of embryonic stem cell cultures through the temporal expression of vascular endothelial growth factor receptors in an ARNT-dependent manner. Stem Cells 28:799–809
Sano S, Eto K, Takayama N (2011) Culture method related to differentiation of pluripotent stem cells into blood cells. Patent. PCT/JP2011/070563
Acknowledgments
The authors thank Dr. Naoshi Sugimoto and Dr. Peter Karangiannis for critical reading of the manuscript. This work was supported in part by the Highway Program for Realization of Regenerative Medicine (JP18bm0504008, K.E.) and the Core Center for iPS Cell Research (JP18bm0104001, K.E.) from the Japan Agency for Medical Research and Development (AMED), and by Grant-in-Aid for JSPS fellow (JP18J14237, A.Y.) and for scientific research (18H04164, K.E.) from the Japan Society for the Promotion of Science (JSPS).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Yuzuriha, A., Eto, K. (2021). Revised “hPSC-Sac Method” for Simple and Efficient Differentiation of Human Pluripotent Stem Cells to Hematopoietic Progenitor Cells. In: Nagy, A., Turksen, K. (eds) Induced Pluripotent Stem (iPS) Cells. Methods in Molecular Biology, vol 2454. Humana, New York, NY. https://doi.org/10.1007/7651_2021_443
Download citation
DOI: https://doi.org/10.1007/7651_2021_443
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2118-9
Online ISBN: 978-1-0716-2119-6
eBook Packages: Springer Protocols